Children with inflammatory bowel disease* (IBD) may have difficulty functioning in school, particularly because their tendency to internalize problems can impact attendance. These are the findings from a Nationwide Children's Hospital study appearing in the Journal of Developmental & Behavioral Pediatrics. "Both IBD and its treatment have the potential to disrupt school functioning, " said Wallace V. Crandall, MD, director of the Center for Pediatric and Adolescent Inflammatory Bowel Disease at Nationwide Children's and study author. "Primary symptoms of IBD include abdominal pain, fatigue and diarrhea. Corticosteroids affect learning and memory and intravenous medication requiring hours in an infusion clinic." Some research suggests that youth with IBD may have increased absences, but little is known about other areas of school functioning or related factors.
Inflammatory bowel disease (IBD) travelers have an increased risk of illness during trips to industrialized countries, but not to developing or tropical regions, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association. "Inflammatory bowel disease patients are often advised to avoid travel, especially to the developing world. However, we found that the absolute risk of illness is small and most episodes were mild, " said Shomron Ben-Horin, MD, of the Sheba Medical Center in Tel Hashomer, Israel and lead author of this study. "If an inflammatory bowel disease patient has been in remission for at least three months, I recommend they take their dream vacation." In this study, doctors studied 222 IBD patients and 224 healthy individuals (controls) during 1, 099 total trips.
A long-term U.S. study published online in GUT has shown that living in sunnier climates may lower the chances of developing inflammatory bowel disease, especially in those aged 30 years or over. The researchers' findings, which support earlier European research, could potentially lead to new therapies and preventive measures. Crohn's disease and ulcerative colitis are both inflammatory bowel diseases (IBD) that can be extremely painful, need extensive surgery, and often severely affect the individual's quality of life. Even though recent advances have identified genetic factors that are likely to be involved in the development of IBD, its causes continue to remain largely unknown. The researchers state that given that the overall genetic risk is low to moderate, factors like environment and lifestyle are likely to play a key role.
The incidence and prevalence of inflammatory bowel disease (IBD) are increasing with time and in different regions around the world, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. "Insight into the worldwide epidemiology of inflammatory bowel disease is important for the identification of geographic patterns and time trends, " said Gilaad G. Kaplan, MD, MPH, of the University of Calgary and lead author of this study. "Our findings will help researchers estimate the global public health burden of inflammatory bowel disease so that appropriate health-care resources are allocated, and targeted research is conducted in specific geographic regions, " added Dr. Kaplan, an Alberta Innovates - Health Solutions population health investigator.
About one in ten women of child-bearing age suffers from endometriosis, a fairly common condition in which cells from the lining of the uterus grow in other areas of the body. According to a study published in Gut, women with endometriosis are almost twice as likely to develop inflammatory bowel disease compared to other females. The effect can last for up to 20 years following an endometriosis diagnosis. Endometriosis and inflammatory bowel disease are both chronic inflammatory disorders that affect the bowel and cause abdominal pain. Both disorders commonly start in young adults. Researchers monitored the long-term health of over 37, 000 Danish women who were hospitalized with endometriosis between 1977 and 2007 for an average period of 13 years. During this monitoring period, 320 of these women developed inflammatory bowel disease, of which 228 were diagnosed with ulcerative colitis and 92 with Crohn's disease.